Asbestos-activated peritoneal macrophages release a factor(s) which inhibits lymphocyte mitogenesis.

Intraperitoneal asbestos injection in mice has previously been reported to elicit an activated macrophage population. In the present study supernatants from such macrophages were tested for their effect on thymocyte mitogenesis in response to concanavalin A; control supernatants were obtained from saline- and latex-elicited macrophages. Supernatants from asbestos-elicited macrophages were significantly inhibitory to thymocyte mitogenesis while saline- and latex-elicited macrophages did not release significant amounts of such activity. Asbestos-activated macrophage supernatants were inhibitory in a dose-dependent way and the activity was not secreted by macrophages from mice which had received asbestos in the long term. The inhibitory activity was partially dialysable. Supernatants prepared by treating macrophages in vitro with a lethal dose of asbestos were not inhibitory suggesting that the inhibitory activity in the supernatants of asbestos-activated macrophages did not leak from dead or dying cells. The asbestos macrophage supernatant was also significantly inhibitory to mature T-cell-enriched spleen cells but had no effect on fibroblasts, suggesting that the inhibitory effect could be lymphoid cell specific.

[1]  D. Lee,et al.  Asbestos and Disease , 1978 .

[2]  E. Kagan,et al.  Manifestations of cellular immunity in the rat after prolonged asbestos inhalation. II. Alveolar macrophage-induced splenic lymphocyte proliferation. , 1981, Environmental research.

[3]  L. Davis,et al.  Signals involved in T cell activation. I. Phorbol esters enhance responsiveness but cannot replace intact accessory cells in the induction of mitogen-stimulated T cell proliferation. , 1985, Journal of immunology.

[4]  A. Allison,et al.  Asbestos induces selective release of lysosomal enzymes from mononuclear phagocytes , 1974, Nature.

[5]  E. Unanue,et al.  Stimulation of nonlymphoid mesenchymal cell proliferation by a macrophage-derived growth factor. , 1981, Journal of immunology.

[6]  G. Currie.  Promotion of fibrosarcoma cell growth by products of syngeneic host macrophages. , 1981, British Journal of Cancer.

[7]  J. Merchant,et al.  Lymphocyte responses to phytohaemagglutinin in patients with asbestosis and pleural mesothelioma. , 1978, Clinical and experimental immunology.

[8]  R. Ross,et al.  A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. , 1976, The American journal of pathology.

[9]  J. Remington,et al.  Studies on the regulation of lymphocyte reactivity by normal and activated macrophages. , 1977, Cellular immunology.

[10]  P. Holt.  Alveolar macrophages. IV. Interspecies differences in activity in proliferating lymphocyte cultures. , 1980, Cellular immunology.

[11]  P. Simon,et al.  Endogenous pyrogens made by rabbit peritoneal exudate cells are identical with lymphocyte-activating factors made by rabbit alveolar macrophages. , 1980, Journal of immunology.

[12]  I. Gery,et al.  POTENTIATION OF THE T-LYMPHOCYTE RESPONSE TO MITOGENS , 1972, The Journal of experimental medicine.

[13]  K. Miller.  Alterations in the surface-related phenomena of alveolar macrophages following inhalation of crocidolite asbestos and quartz dusts: an overview. , 1979, Environmental research.

[14]  J. Salvaggio,et al.  Diminished suppressor cell function in patients with asbestosis. , 1981, Clinical and experimental immunology.

[15]  S. Mizel.  Physicochemical characterization of lymphocyte-activating factor (LAF). , 1979, Journal of immunology.

[16]  E. Unanue.  Cooperation between mononuclear phagocytes and lymphocytes in immunity. , 1980, The New England journal of medicine.

[17]  L. Varesio,et al.  Suppression of lymphokine production. I. Macrophage-mediated inhibition of MIF production. , 1980, Cellular immunology.

[18]  Y. Yamamura,et al.  Committee on Maternal Welfare. Concealed hemorrhage. , 1974 .

[19]  K. Donaldson,et al.  Interactions of asbestos-activated macrophages with an experimental fibrosarcoma. , 1983, Environmental health perspectives.

[20]  A. Allison.  Mechanisms by which Activated Macrophages Inhibit Lymphocyte Responses , 1978, Immunological reviews.

[21]  J. Gluckman,et al.  Immunological studies of patients with asbestosis. I. Studies of cell-mediated immunity. , 1977, Clinical and experimental immunology.

[22]  Y. Kubota,et al.  Enhanced Interleukin 1 Production by Alveolar Macrophages and Increase in Ia‐Positive Lung Cells in Silica‐Exposed Rats , 1986, Microbiology and immunology.

[23]  R. Keller.  19 – Cytostatic and Cytocidal Effects of Activated Macrophages , 1976 .

[24]  H. Chapman,et al.  The macrophage as an antineoplastic surveillance cell: biological perspectives. , 1978, Journal of the Reticuloendothelial Society.

[25]  R. Handschumacher,et al.  Purification and properties of human lymphocyte activating factor (LAF). , 1977, Journal of immunology.

[26]  E. Kagan,et al.  The in vivo effects of asbestos on macrophage membrane structure and population characteristics of macrophages: a scanning electron microscope study. , 1976, Journal of the Reticuloendothelial Society.

[27]  F. Kuehl,et al.  Macrophages synthesise and release prostaglandins in response to inflammatory stimuli , 1977, Nature.

[28]  M. Rola-Pleszczynski,et al.  Phospholipase A activity and prostaglandin release from alveolar macrophages exposed to asbestos. , 1980, Prostaglandins and medicine.

[29]  E. Lederer,et al.  Stimulation of thymocyte mitogenic protein secretion and of cytostatic activity of mouse peritoneal macrophages by trehalose dimycolate and muramyl‐dipeptide , 1980, European journal of immunology.

[30]  L. Wahl,et al.  Suppressor monocytes in human disease: a review. , 1979, Advances in experimental medicine and biology.

[31]  J. Vassalli,et al.  Macrophage plasminogen activator: induction by asbestos is blocked by anti-inflammatory steroids , 1976, The Journal of experimental medicine.

[32]  D. Taramelli,et al.  Suppression of lymphokine production: II. Macrophage-dependent inhibition of production of macrophage activating factor. , 1981, Cellular immunology.

[33]  C. Henney,et al.  BCG-induced suppressor cells. I. Demonstration of a macrophage-like suppressor cell that inhibits cytotoxic T cell generation in vitro. , 1978, Journal of immunology.

[34]  R. Messner,et al.  Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell , 1977, The Journal of experimental medicine.

[35]  S. Nakamura,et al.  Production of a lymphocyte proliferation potentiating factor by purified polymorphonuclear leucocytes from mice and rabbits. , 1984, Immunology.

[36]  K. Donaldson,et al.  Characteristics of peritoneal macrophages induced by asbestos injection. , 1982, Environmental research.